Evidence map›Paper›PMID 31940376›Full record

Trial reportPloS one2020

Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.

Kristen Pickles, Luise Kazda, Alexandra Barratt, Kevin McGeechan, Jolyn Hersch, Kirsten McCaffery

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristen PicklesSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID 0000-0002-1621-3217
Luise KazdaSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID 0000-0003-4105-0402
Alexandra BarrattSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Kevin McGeechanSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Jolyn HerschSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID 0000-0001-5225-6639
Kirsten McCafferySydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID 0000-0003-2696-5006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAustralian clinicians are advised to 'offer evidence-based decisional support to men considering whether or not to have a PSA test'. This randomised trial compared the performance and acceptability of two new decision aids (DAs) to aid men in making informed choices about PSA screening.

methods~3000 Australian men 45-60 years with varying educational attainment were recruited via an online panel and randomised to view one of two online decision aids (one full length, one abbreviated) and completed a questionnaire. The primary outcome was informed choice about PSA screening.

findingsSignificantly more men in the long DA group (38%) made an informed choice than men who received the shorter DA (33%) (95% CI 1.1% to 8.2%; p = 0.008). On knowledge, the long DA group scored, on average, 0.45 points higher than the short DA group (95% CI 0.14 to 0.76; p = 0.004) and 5% more of the participants achieved an adequate knowledge score (95% CI 1.9% to 8.8%; p = 0.002). Men allocated the long DA were less likely to intend to have a PSA test in the future (53%) than men in the short DA group (59%). Both DAs rated highly on acceptability.

conclusionsBoth DAs were useful and acceptable to men regardless of education level and both supported informed decision making. The long version resulted in higher knowledge, and a higher proportion of men able to make an informed choice, but the differences were small. Long DAs may be useful for men whose informational needs are not satisfied by a short DA.

Indexed as

Early Detection of CancerPsychometricsAustraliaDecision MakingDecision Support TechniquesHumansMaleMiddle AgedProstate-Specific AntigenProstatic NeoplasmsSurveys and QuestionnairesProstate-Specific Antigen

Identifiers

PMID31940376
PMCPMC6961909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.